Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
NAGE

Market Cap: $242.12M

NI

Niagen Bioscience Inc

NAGE

NASDAQ (NASDAQ Capital Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin64.24%

EBITDA Margin14.32%

EBIT Margin12.91%

Pre-tax Margin13.19%

Net Profit Margin12.39%

Earnings Yield6.63%

Valuation Multiples

Price / Book2.92

Price / Sales1.88

Price / Earnings15.65

PEG-0.90

Forward PEG2.10

EV / Sales1.38

EV / EBITDA9.62

EV / Operating Cash Flow29.87

EV / Free Cash Flow31.32

Price / Free Cash Flow42.67

Price / Operating Cash Flow40.53

Cash Flow & Capital

Free Cash Flow / Share$0.07

Operating Cash Flow / Share$0.07

Free Cash Flow Yield2.34%

Capex / Revenue0.21%

Capex / Operating Cash Flow4.62%

Capex / Depreciation0.17

Stock Compensation / Revenue5.38%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio6.50

Quick Ratio5.13

Cash Ratio4.43

Debt / Assets0.02

Debt / Capital0.03

Debt / Equity0.03

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA-3.49

Solvency Ratio0.74

Financial Leverage1.29

Efficiency & Working Capital

Asset Turnover1.21

Fixed Asset Turnover41.82

Inventory Turnover2.24

Receivables Turnover15.04

Payables Turnover4.89

Days Sales Outstanding24.26

Days Inventory Outstanding163.2

Days Payables Outstanding74.63

Operating Cycle187.46

Cash Conversion Cycle112.83

Working Capital Turnover1.56

Returns & Quality

Return on Equity20.50%

Return on Assets15.00%

Return on Invested Capital8.75%

ROCE9.41%

Return on Tangible Assets15.79%

Operating Return on Assets7.80%

Income Quality0.37

Tax Burden0.94

Interest Burden1.02

Balance Sheet & Intrinsic Metrics

Enterprise Value$177.71M

Invested Capital$91.13M

Working Capital$82.74M

Tangible Asset Value$77.22M

Net Current Asset Value$73.73M

Graham Number$2.17

Graham Net-Net$0.75

Book Value / Share$1.04

Tangible Book Value / Share$0.97

Cash / Share$0.84

Financial Health Scores

Piotroski Score4

Altman Z-Score6.69

Revenue$129.08M

EBIT$16.66M

Market Cap$244.51M

Working Capital$82.74M

Retained Earnings$-157.25M

Total Assets$106.59M

Total Liabilities$24.06M